PAGAN ELEONORA

Pala, L., Sala, I., Pagan, E., De Pas, T., Zattarin, E., Catania, C., et al. (2024). "Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer.". BREAST, 73(February 2024) [10.1016/j.breast.2024.103672]. Dettaglio

Sala, I., Pagan, E., Pala, L., Oriecuia, C., Musca, M., Specchia, C., et al. (2024). Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis. FRONTIERS IN IMMUNOLOGY, 15 [10.3389/fimmu.2024.1340979]. Dettaglio

Pala, L., De Pas, T., Pagan, E., Sala, I., Catania, C., Zattarin, E., et al. (2023). Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials. THE BREAST, 69(June 2023), 258-264 [10.1016/j.breast.2023.02.012]. Dettaglio

Addetia, K., Mazzanti, A., Maragna, R., Monti, L., Yamat, M., Kukavica, D., et al. (2023). Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy. EUROPEAN HEART JOURNAL. CARDIOVASCULAR IMAGING, 24(5), 664-667 [10.1093/ehjci/jeac172]. Dettaglio

Pala, L., De Pas, T., Pagan, E., Minucci, S., Catania, C., Digiacomo, N., et al. (2023). Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis. SEMINARS IN ONCOLOGY, 50(1-2), 34-39 [10.1053/j.seminoncol.2023.03.003]. Dettaglio